Completed
Polymorphic Effects of Cytochrome P450 3A5 on Pharmacokinetics of Maraviroc and Its Metabolites
NCT01980329
- Conditions
- Cytochrome P450 CYP3A5 Enzyme Polymorphism, Healthy Subjects, Pharmacokinetics of Maraviroc
- Locations
-
- The Johns Hopkins University School of Medicine Division of Clinical Pharmacology Baltimore, Maryland, United States